Search
Conmed Corp
CNMDAdd to Watchlist
33.830USD
+1.070+3.27%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.02BMarket Cap
19.08P/E TTM
More Details of Conmed Corp Company
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Conmed Corp Info
Ticker SymbolCNMD
Company nameConmed Corp
IPO dateJul 23, 1987
CEOBeyer (Patrick J)
Number of employees3900
Security typeOrdinary Share
Fiscal year-endJul 23
Address11311 Concept Boulevard
CityLARGO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code33773
Phone17272142974
Websitehttps://www.conmed.com/
Ticker SymbolCNMD
IPO dateJul 23, 1987
CEOBeyer (Patrick J)
Company Executives of Conmed Corp
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.04K
-8.65%
Mr. Charles (Chuck) Farkas
Mr. Charles (Chuck) Farkas
Independent Director
Independent Director
--
--
Ms. Johonna Marie Pelletier
Ms. Johonna Marie Pelletier
Treasurer and Vice President - Tax
Treasurer and Vice President - Tax
--
--
Mr. Todd W. Garner
Mr. Todd W. Garner
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
FAQs
Who are the top five shareholders of Conmed Corp?
The top five shareholders of Conmed Corp are: Mr. David M. Bronson
How many institutions hold shares of Conmed Corp (CNMD)?
As of 2026Q1, 638 institutions hold shares of Conmed Corp, with a combined market value of approximately 34.51M, accounting for 114.61% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -7041128.00.
What is the biggest source of revenue for Conmed Corp?
In 2026Q1, the General Surgery business generated the highest revenue for Conmed Corp, amounting to 800.13M and accounting for 58.20% of total revenue.